Literature DB >> 1548132

[Immune phenotyping of mononuclear infiltrate in bullous pemphigoid].

A Ambach1, D Zillikens, B Klingert, A A Hartmann, G Burg.   

Abstract

In bullous pemphigoid, autoantibodies alone are not capable of blister formation. In addition, they need complement and various inflammatory cells. The role of mononuclear cells, however, is poorly understood. Therefore, we studied the inflammatory infiltrate in 21 patients with bullous pemphigoid and 11 controls (normal skin, n = 5; eczematous skin, n = 6) using a panel of monoclonal antibodies. In bullous pemphigoid, 60% of the mononuclear infiltrate consists of CD3+ T-lymphocytes, while 25% represents monocytes/macrophages (MOMA); B-lymphocytes are absent. In the area of the basement zone (BMZ), which was studied separately, MOMA predominate. In 30% of bullous pemphigoid biopsies we found a close, almost linear attachment of MOMA to the BMZ. Along the BMZ, lymphocytes belong to the CD3+, CD4+ T-helper subset. CD8+ T-cytotoxic-suppressor cells, however, are rarely encountered there, and other cytotoxic lymphocytes are not found at all. All lymphocytes along the BMZ are memory cells. In small, early bullous pemphigoid lesions, MOMA are frequently the only effector cells. Eosinophilic granulocytes are rare in these lesions. Our findings suggest that mononuclear cells, and particularly MOMA, may be more important than believed hitherto in the inflammatory process resulting in separation of the BMZ.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1548132

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  7 in total

1.  Detection of elevated levels of IL-4, IL-6, and IL-10 in blister fluid of bullous pemphigoid.

Authors:  E Schmidt; B Bastian; R Dummer; H P Tony; E B Bröcker; D Zillikens
Journal:  Arch Dermatol Res       Date:  1996-06       Impact factor: 3.017

2.  Immunohistological analysis of immune cells in blistering skin lesions.

Authors:  Mahmoud R Hussein; Fayed Mahammad Nagy Ali; Abd-Elhady M M Omar
Journal:  J Clin Pathol       Date:  2007-01       Impact factor: 3.411

3.  Elevated levels of soluble tumour necrosis factor receptor I in blister fluids of bullous pemphigoid and suction blisters.

Authors:  A Zentner; J Rendl; I Grelle; R Dummer; E B Bröcker; D Zillikens
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

4.  Mast cell-deficient mice Mcpt5Cre/Dicer fl/fl redefine the role of mast cells in experimental bullous pemphigoid.

Authors:  S Nsiah-Dosu; C Scholz; Z Orinska; C D Sadik; R J Ludwig; E Schmidt; D Zillikens; K Hartmann
Journal:  Skin Health Dis       Date:  2021-12-21

5.  The interleukin-2 receptor in lesions and serum of bullous pemphigoid.

Authors:  D Zillikens; A Ambach; M Schuessler; R Dummer; A A Hartmann; G Burg
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

6.  Correlation between IL36α and IL17 and Activity of the Disease in Selected Autoimmune Blistering Diseases.

Authors:  Agnieszka Żebrowska; Anna Woźniacka; Katarzyna Juczyńska; Kamila Ociepa; Elżbieta Waszczykowska; Izabela Szymczak; Rafał Pawliczak
Journal:  Mediators Inflamm       Date:  2017-05-10       Impact factor: 4.711

Review 7.  Epidermolysis Bullosa Acquisita: The 2019 Update.

Authors:  Hiroshi Koga; Catherine Prost-Squarcioni; Hiroaki Iwata; Marcel F Jonkman; Ralf J Ludwig; Katja Bieber
Journal:  Front Med (Lausanne)       Date:  2019-01-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.